Company
About Tailored Bio
Tailored Bio Co., Ltd. (주식회사 테일러드바이오) is a veterinary microbiome platform company focused on developing disease-targeted functional ingredients for companion-animal health.
- Legal name
- Tailored Bio Co., Ltd. · 주식회사 테일러드바이오
- Category
- Veterinary microbiome platform company
- Country
- South Korea
- Representative director
- 배기덕
- Business registration
- 812-81-04145
- Lead programme
- BP121 — Ligilactobacillus salivarius BP121 (KCCM12170P)
What is Tailored Bio?
Tailored Bio Co., Ltd. is a South Korea-based veterinary microbiome platform company. It develops microbiome-based functional ingredients aimed at specific companion-animal health problems, rather than general-purpose supplements.
What does Tailored Bio develop?
The current development focus is companion-animal renal health. The lead programme centres on BP121, a defined Ligilactobacillus salivarius strain (formerly Lactobacillus salivarius; deposit KCCM12170P), subject to applicable licensing arrangements.
Research and development interests include:
- Companion-animal renal health
- The gut–kidney axis
- Kidney-microbiome research and gut-derived uremic toxins
- Functional probiotics and microbiome-derived ingredients
- Scientific commercialisation through veterinary and B2B ingredient channels
Is Tailored Bio the same company as Tailored Probio?
No — they are distinct legal entities with distinct roles.
Tailored Bio is a veterinary microbiome platform company developing functional ingredients for companion animals, including BP121.
Tailored Probio is a separate company that imports and distributes microbiome products and functional ingredients. It is the official distributor of Renadyl® in South Korea. Renadyl® is marketed by Kibow Biotech, is not a Tailored Bio product, and does not contain BP121.
What scientific fields does Tailored Bio work in?
Companion-animal renal health, the gut–kidney axis, kidney-microbiome research, and functional probiotics.
Tailored Bio's companion-animal renal-health work is a research and development focus. It must not be described as an established treatment, prevention, or cure for kidney disease in dogs or cats. Any such statement would require directly relevant veterinary evidence and appropriate regulatory review.